Drug prices consistently surpass inflation rates
Klien 24 (Hayden E. Klien, Hayden is an assistant editor for The American Journal of Managed Care, 01/31/2024, "Drug Prices and OOP Costs Increased Beyond Inflation Rates 2009-2018, But Were Not Related," AJMC, https://www.ajmc.com/view/drug-prices-and-oop-costs-increased-beyond-inflation-rates-2009-2018-but-were-not-related, DA: 06/29/24) tk-wh
Drug prices in the US increased 4.4% annually and median out-of-pocket (OOP) costs increased 9.6% annually from 2009 to 2018, but there was no direct link between these amounts for individual drugs.
Between 2009 and 2018, drug prices in the US increased at an annual rate of 4.4% while median out-of-pocket (OOP) costs increased 9.6% per year. However, researchers say there was no link between these increases for individual drugs.
Prescription drugs administered in clinics or hospitals, including infusions and injections, constitute approximately one-third of prescription drug spending in the US, and previous research has shown that patient OOP costs for pharmacy-administered drugs increased with rising drug prices. However, it remained unclear whether a similar trend existed for clinician-administered drugs.